Analgesic ineffectiveness of lacosamide after spinal nerve ligation and its sodium channel activity in injured neurons

T. Hagenacker, N. Schäfer, Dietrich Busselberg, Maria Schäfers

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Lacosamide is a novel anti-epileptic drug that enhances the slow- and not fast-inactivating state of voltage-gated sodium channels. Lacosamide has demonstrated analgesic efficacy in several animal studies but preclinical studies on neuropathic pain models are rare, and recent clinical trials showed no superior analgesic effects. Methods: Here, we examine whether an acute or chronic administration of lacosamide (3-60 mg/kg, i.p.) attenuates pain behaviour induced by spinal nerve ligation (SNL). To validate the inhibitory efficacy of lacosamide on voltage-gated sodium channels, sodium currents in naïve and SNL-injured dorsal root ganglion (DRG) neurons were recorded using whole-cell patch clamping. Results: Lacosamide only marginally attenuated thermal hyperalgesia, but not tactile allodynia when applied once 7 or 14 days after SNL and showed no analgesic effect when applied daily for 19 days. In naïve neurons, 100 μmol/L lacosamide inhibited sodium channel currents by 58% and enhanced the slow inactivation (87% for lacosamide vs. 47% for control). In contrast, lacosamide inhibited sodium currents in injured DRG neurons by only 15%, while the effects on slow inactivation were diminished. Isolated currents from the NaV1.8 channel subtype were only marginally changed by lacosamide. Conclusion: The reduced effectiveness of lacosamide on voltage-gated sodium channel currents in injured DRG neurons may contribute to the reduced analgesic effect observed for the SNL model.

Original languageEnglish
Pages (from-to)881-892
Number of pages12
JournalEuropean Journal of Pain (United Kingdom)
Volume17
Issue number6
DOIs
Publication statusPublished - Jul 2013

Fingerprint

Spinal Nerves
Sodium Channels
Ligation
Analgesics
Neurons
Voltage-Gated Sodium Channels
Spinal Ganglia
Hyperalgesia
Sodium
lacosamide
Neuralgia
Constriction
Clinical Trials
Pain

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Analgesic ineffectiveness of lacosamide after spinal nerve ligation and its sodium channel activity in injured neurons. / Hagenacker, T.; Schäfer, N.; Busselberg, Dietrich; Schäfers, Maria.

In: European Journal of Pain (United Kingdom), Vol. 17, No. 6, 07.2013, p. 881-892.

Research output: Contribution to journalArticle

@article{315dcb4e045f41669d62d193504f9747,
title = "Analgesic ineffectiveness of lacosamide after spinal nerve ligation and its sodium channel activity in injured neurons",
abstract = "Background: Lacosamide is a novel anti-epileptic drug that enhances the slow- and not fast-inactivating state of voltage-gated sodium channels. Lacosamide has demonstrated analgesic efficacy in several animal studies but preclinical studies on neuropathic pain models are rare, and recent clinical trials showed no superior analgesic effects. Methods: Here, we examine whether an acute or chronic administration of lacosamide (3-60 mg/kg, i.p.) attenuates pain behaviour induced by spinal nerve ligation (SNL). To validate the inhibitory efficacy of lacosamide on voltage-gated sodium channels, sodium currents in na{\"i}ve and SNL-injured dorsal root ganglion (DRG) neurons were recorded using whole-cell patch clamping. Results: Lacosamide only marginally attenuated thermal hyperalgesia, but not tactile allodynia when applied once 7 or 14 days after SNL and showed no analgesic effect when applied daily for 19 days. In na{\"i}ve neurons, 100 μmol/L lacosamide inhibited sodium channel currents by 58{\%} and enhanced the slow inactivation (87{\%} for lacosamide vs. 47{\%} for control). In contrast, lacosamide inhibited sodium currents in injured DRG neurons by only 15{\%}, while the effects on slow inactivation were diminished. Isolated currents from the NaV1.8 channel subtype were only marginally changed by lacosamide. Conclusion: The reduced effectiveness of lacosamide on voltage-gated sodium channel currents in injured DRG neurons may contribute to the reduced analgesic effect observed for the SNL model.",
author = "T. Hagenacker and N. Sch{\"a}fer and Dietrich Busselberg and Maria Sch{\"a}fers",
year = "2013",
month = "7",
doi = "10.1002/j.1532-2149.2012.00260.x",
language = "English",
volume = "17",
pages = "881--892",
journal = "European Journal of Pain",
issn = "1090-3801",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Analgesic ineffectiveness of lacosamide after spinal nerve ligation and its sodium channel activity in injured neurons

AU - Hagenacker, T.

AU - Schäfer, N.

AU - Busselberg, Dietrich

AU - Schäfers, Maria

PY - 2013/7

Y1 - 2013/7

N2 - Background: Lacosamide is a novel anti-epileptic drug that enhances the slow- and not fast-inactivating state of voltage-gated sodium channels. Lacosamide has demonstrated analgesic efficacy in several animal studies but preclinical studies on neuropathic pain models are rare, and recent clinical trials showed no superior analgesic effects. Methods: Here, we examine whether an acute or chronic administration of lacosamide (3-60 mg/kg, i.p.) attenuates pain behaviour induced by spinal nerve ligation (SNL). To validate the inhibitory efficacy of lacosamide on voltage-gated sodium channels, sodium currents in naïve and SNL-injured dorsal root ganglion (DRG) neurons were recorded using whole-cell patch clamping. Results: Lacosamide only marginally attenuated thermal hyperalgesia, but not tactile allodynia when applied once 7 or 14 days after SNL and showed no analgesic effect when applied daily for 19 days. In naïve neurons, 100 μmol/L lacosamide inhibited sodium channel currents by 58% and enhanced the slow inactivation (87% for lacosamide vs. 47% for control). In contrast, lacosamide inhibited sodium currents in injured DRG neurons by only 15%, while the effects on slow inactivation were diminished. Isolated currents from the NaV1.8 channel subtype were only marginally changed by lacosamide. Conclusion: The reduced effectiveness of lacosamide on voltage-gated sodium channel currents in injured DRG neurons may contribute to the reduced analgesic effect observed for the SNL model.

AB - Background: Lacosamide is a novel anti-epileptic drug that enhances the slow- and not fast-inactivating state of voltage-gated sodium channels. Lacosamide has demonstrated analgesic efficacy in several animal studies but preclinical studies on neuropathic pain models are rare, and recent clinical trials showed no superior analgesic effects. Methods: Here, we examine whether an acute or chronic administration of lacosamide (3-60 mg/kg, i.p.) attenuates pain behaviour induced by spinal nerve ligation (SNL). To validate the inhibitory efficacy of lacosamide on voltage-gated sodium channels, sodium currents in naïve and SNL-injured dorsal root ganglion (DRG) neurons were recorded using whole-cell patch clamping. Results: Lacosamide only marginally attenuated thermal hyperalgesia, but not tactile allodynia when applied once 7 or 14 days after SNL and showed no analgesic effect when applied daily for 19 days. In naïve neurons, 100 μmol/L lacosamide inhibited sodium channel currents by 58% and enhanced the slow inactivation (87% for lacosamide vs. 47% for control). In contrast, lacosamide inhibited sodium currents in injured DRG neurons by only 15%, while the effects on slow inactivation were diminished. Isolated currents from the NaV1.8 channel subtype were only marginally changed by lacosamide. Conclusion: The reduced effectiveness of lacosamide on voltage-gated sodium channel currents in injured DRG neurons may contribute to the reduced analgesic effect observed for the SNL model.

UR - http://www.scopus.com/inward/record.url?scp=84879587818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879587818&partnerID=8YFLogxK

U2 - 10.1002/j.1532-2149.2012.00260.x

DO - 10.1002/j.1532-2149.2012.00260.x

M3 - Article

VL - 17

SP - 881

EP - 892

JO - European Journal of Pain

JF - European Journal of Pain

SN - 1090-3801

IS - 6

ER -